Breast Cancer Drug Studies Rife with Spin, Bias | GenomeWeb

Reports of breast cancer drug trials in the scientific literature are far from fair and balanced, according to researchers at the University of Toronto this week

The group published a study in Annals of Oncology yesterday showing that outcomes from phase III breast cancer trials are widely reported with both spin and bias.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.